A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib

Saved in:
Bibliographic Details
Published in:Leukemia research 2010-09, Vol.34 (9), p.e240-e242
Main Authors: Cea, Michele, Cirmena, Gabriella, Garuti, Anna, Rocco, Ilaria, Palermo, Claudia, Cagnetta, Antonia, Moran, Eva, Colombo, Nicoletta, Grasso, Raffaella, Fugazza, Giuseppina, Gobbi, Marco, Nencioni, Alessio, Ballestrero, Alberto, Patrone, Franco
Format: Article
Language:English
Subjects:
Aged
Antineoplastic Agents - therapeutic use
Dasatinib
Female
Genes, abl
Hematology, Oncology and Palliative Medicine
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics
Mutation
Pyrimidines - therapeutic use
Thiazoles - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0145-2126
1873-5835
DOI:10.1016/j.leukres.2010.03.036